InvestorsHub Logo
Followers 145
Posts 27565
Boards Moderated 3
Alias Born 02/07/2004

Re: None

Tuesday, 04/11/2017 1:18:27 AM

Tuesday, April 11, 2017 1:18:27 AM

Post# of 3881
FBR & Co reaffirmed their buy rating on shares of RedHill Biopharma Ltd – (NASDAQ:RDHL) in a report released on Wednesday.
A number of other equities analysts have also recently issued reports on RDHL. Zacks Investment Research upgraded RedHill Biopharma Ltd – from a sell rating to a buy rating and set a $12.00 target price on the stock in a report on Thursday, January 19th. HC Wainwright set a $33.00 target price on RedHill Biopharma Ltd – and gave the stock a buy rating in a report on Saturday, February 25th.

https://sportsperspectives.com/2017/04/10/fbr-co-reaffirms-buy-rating-for-redhill-biopharma-ltd-rdhl.html
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RDHL News